Published in J Transl Med on October 06, 2011
Pathogenesis of IgA nephropathy. Nat Rev Nephrol (2012) 1.22
Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway. PLoS One (2013) 0.89
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev (2007) 21.13
Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes (2006) 5.29
The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med (1987) 3.99
Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol (2002) 2.94
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science (1988) 2.93
NADPH oxidases in the kidney. Antioxid Redox Signal (2006) 2.70
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int (2003) 2.13
Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension (2009) 2.04
Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc Natl Acad Sci U S A (2003) 2.03
Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. Lancet (1988) 1.97
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension (2006) 1.91
The new biology of aldosterone. J Endocrinol (2005) 1.84
Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension (2004) 1.72
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int (2002) 1.68
Role of aldosterone in the remnant kidney model in the rat. J Clin Invest (1996) 1.65
NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal (2002) 1.64
Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl (2000) 1.38
Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation (2001) 1.19
Reconsidering the roles of the mineralocorticoid receptor. Hypertension (2009) 1.17
Aldosterone in the development and progression of renal injury. Kidney Int (2004) 1.10
RALES, EPHESUS and redox. J Steroid Biochem Mol Biol (2005) 1.09
Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Kidney Int (2005) 1.07
Suppressing renal NADPH oxidase to treat diabetic nephropathy. Expert Opin Ther Targets (2007) 1.06
Effect of aldosterone on renal transforming growth factor-beta. Am J Physiol Renal Physiol (2004) 1.02
Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol Med (2002) 1.00
Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol (2005) 1.00
Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. Nephrol Dial Transplant (2007) 0.97
Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis (1995) 0.95
Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am J Cardiol (2004) 0.94
The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep (2006) 0.93
Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study. Am J Kidney Dis (2005) 0.93
ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am J Kidney Dis (1999) 0.91
Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol (2003) 0.91
Human renal mesangial cells produce aldosterone in response to low-density lipoprotein (LDL). J Steroid Biochem Mol Biol (2005) 0.91
Aldosterone promotes fibronectin production through a Smad2-dependent TGF-beta1 pathway in mesangial cells. Biochem Biophys Res Commun (2006) 0.90
Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int (2004) 0.86
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int (2003) 0.86
Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension (2000) 0.86
Combination therapy with aldosterone blockade and renin-angiotensin inhibitors confers organ protection. Hypertens Res (2006) 0.85
Aldosterone in progressive renal disease. Semin Nephrol (2001) 0.85
Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy. Kidney Int (1996) 0.84
Mechanisms of tubulointerstitial injury in IgA nephropathy. Kidney Int Suppl (2005) 0.83
Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis (1993) 0.83
Aldosterone and renal injury. Nihon Yakurigaku Zasshi (2004) 0.82
NADPH oxidase in the kidney: a Janus in determining cell fate. Kidney Int (2009) 0.81
In vitro enhanced chemotaxis of CD25+ mononuclear cells in patients with familial IgAN through glomerulotubular interactions. Am J Physiol Renal Physiol (2010) 0.79
Hypertension and the expanding role of aldosterone. Curr Hypertens Rep (2006) 0.77
Identification and characterization of human serum alpha2-HS glycoprotein as a jacalin-bound protein. Biochim Biophys Acta (1995) 0.76
Eplerenone: selective aldosterone antagonism in management of cardiovascular and renal disease. J Am Pharm Assoc (2003) (2004) 0.76
Clinical course and outcomes of single-organism Enterococcus peritonitis in peritoneal dialysis patients. Perit Dial Int (2011) 2.19
Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients. Perit Dial Int (2006) 1.84
Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol (2011) 1.72
Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest (2003) 1.51
Potential benefit of plasma exchange in treatment of severe icteric leptospirosis complicated by acute renal failure. Clin Diagn Lab Immunol (2002) 1.44
Retroperitoneal leakage as a cause of ultrafiltration failure. Perit Dial Int (2004) 1.43
Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells? J Cell Physiol (2013) 1.40
Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant (2008) 1.16
Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol (2008) 1.10
Rapid quantification of hepatitis B virus DNA by real-time PCR using fluorescent hybridization probes. J Med Microbiol (2003) 1.10
Real-time quantitative analysis of polyoma BK viremia and viruria in renal allograft recipients. J Virol Methods (2002) 1.10
Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol (2008) 1.07
Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Kidney Int (2005) 1.07
Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses. Nephrol Dial Transplant (2003) 1.06
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. Kidney Int (2013) 1.04
Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int (2005) 1.03
Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial. J Am Soc Nephrol (2013) 1.02
Proliferating cell nuclear antigen (PCNA) as a proliferative marker during embryonic and adult zebrafish hematopoiesis. Histochem Cell Biol (2005) 1.01
Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis. J Am Soc Nephrol (2007) 1.00
Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol (2005) 1.00
A long-term study on hyperlipidemia in stable renal transplant recipients. Clin Transplant (2004) 0.99
Roles of neutrophil gelatinase-associated lipocalin in continuous ambulatory peritoneal dialysis-related peritonitis. J Clin Immunol (2009) 0.97
Macromolecular IgA1 taken from patients with familial IgA nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro. Kidney Int (2009) 0.96
A prospective randomized study on three different peritoneal dialysis catheters. Perit Dial Int (2003) 0.95
A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products. Perit Dial Int (2011) 0.94
Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy. Clin Immunol (2009) 0.93
Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist. J Am Soc Nephrol (2006) 0.93
Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant (2003) 0.92
The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetes. Nephrol Dial Transplant (2010) 0.92
Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy. Nephrol Dial Transplant (2004) 0.92
Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol (2003) 0.91
The role of survivin in angiogenesis during zebrafish embryonic development. BMC Dev Biol (2007) 0.91
In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p16INK4a on melanoma cell lines. Lasers Surg Med (2003) 0.90
Toll-like receptors: sensing and reacting to diabetic injury in the kidney. Nephrol Dial Transplant (2013) 0.89
Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF. Nephrol Dial Transplant (2005) 0.88
Mediators of inflammation and fibrosis. Perit Dial Int (2007) 0.88
Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy. J Clin Lab Anal (2002) 0.87
Bradykinin and high glucose promote renal tubular inflammation. Nephrol Dial Transplant (2009) 0.87
Recurrent hemoperitoneum complicating continuous ambulatory peritoneal dialysis. Perit Dial Int (2002) 0.87
Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int (2004) 0.86
Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy. Pediatr Nephrol (2010) 0.86
The role of leptin and its short-form receptor in inflammation in db/db mice infused with peritoneal dialysis fluid. Nephrol Dial Transplant (2012) 0.86
The renin-angiotensin system. Contrib Nephrol (2011) 0.86
Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis. Nephrol Dial Transplant (2008) 0.84
Additive renoprotective effects of B2-kinin receptor blocker and PPAR-γ agonist in uninephrectomized db/db mice. Lab Invest (2011) 0.84
Mechanisms of tubulointerstitial injury in IgA nephropathy. Kidney Int Suppl (2005) 0.83
Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA--role of MAPK and NF-kappaB. Nephrol Dial Transplant (2007) 0.83
Different effects of amino acid-based and glucose-based dialysate from peritoneal dialysis patients on mesothelial cell ultrastructure and function. Nephrol Dial Transplant (2003) 0.83
Size-dependent binding of IgA to HepG2, U937, and human mesangial cells. J Lab Clin Med (2002) 0.83
Diabetic nephropathy: a global and growing threat. Hong Kong Med J (2010) 0.83
Characteristics of polymeric lambda-IgA binding to leukocytes in IgA nephropathy. J Am Soc Nephrol (2002) 0.82
Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice. Exp Hematol (2010) 0.82
Recent advances in IgA nephropathy--the glomerulopodocytic-tubular communication. Adv Otorhinolaryngol (2011) 0.82
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress. Kidney Int (2016) 0.82
Minimal and optimal peritoneal Kt/V targets: results of an anuric peritoneal dialysis patient's survival analysis. Kidney Int (2005) 0.81
Treatment for lupus nephritis: a revisit. Nephrology (Carlton) (2005) 0.81
Ganoderma extract prevents albumin-induced oxidative damage and chemokines synthesis in cultured human proximal tubular epithelial cells. Nephrol Dial Transplant (2006) 0.81
Distinct role of matrix metalloproteinase-3 in kidney injury molecule-1 shedding by kidney proximal tubular epithelial cells. Int J Biochem Cell Biol (2012) 0.81
Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy. Nephrol Dial Transplant (2009) 0.80
An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjects. PLoS One (2013) 0.80
BMP-7 protects mesangial cells from injury by polymeric IgA. Kidney Int (2008) 0.80
In vitro enhanced chemotaxis of CD25+ mononuclear cells in patients with familial IgAN through glomerulotubular interactions. Am J Physiol Renal Physiol (2010) 0.79
Expression of aquaporin-3 in human peritoneal mesothelial cells and its up-regulation by glucose in vitro. Kidney Int (2002) 0.79
Quantification of BK viral load in asymptomatic renal allograft recipients. Ren Fail (2012) 0.79
Differential effects of advanced glycation end-products on renal tubular cell inflammation. Nephrology (Carlton) (2011) 0.78
Renoprotection by rosiglitazone in accelerated type 2 diabetic nephropathy: Role of STAT1 inhibition and nephrin restoration. Am J Nephrol (2010) 0.78
Normalization of renal aquaporin-2 water channel expression by fosinopril, valsartan, and combination therapy in congestive heart failure: a new mechanism of action. J Mol Cell Cardiol (2004) 0.78
Cancer Incidence and Mortality in Chronic Dialysis Population: A Multicenter Cohort Study. Am J Nephrol (2016) 0.78
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy. Kidney Int (2016) 0.77
Clinical features and genetic analysis of a Chinese kindred with Fabry's disease. Nephrol Dial Transplant (2003) 0.77
Combined blockade of angiotensin II and prorenin receptors ameliorates podocytic apoptosis induced by IgA-activated mesangial cells. Apoptosis (2015) 0.76